Journal
/
Immunology and Infection
/
Adaptation des dosages de cytotoxicité in vivo à l’étude de l’immunodominance dans des réponses cellulaires spécifiques à la tumeur et aux lymphocytes T
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Please note that all translations are automatically generated. Click here for the English version.

Adaptation des dosages de cytotoxicité in vivo à l’étude de l’immunodominance dans des réponses cellulaires spécifiques à la tumeur et aux lymphocytes T

français

Automatically Generated

8,703 Views

•

10:13 min

•

May 06, 2019

DOI:

10.3791/59531-v

DOI:
10.3791/59531-v

•

10:13 min
May 06, 2019

•

5 Views
, ,
1Department of Microbiology and Immunology,Western University, 2Department of Medicine, Division of Clinical Immunology and Allergy,Western University, 3Department of Surgery, Division of General Surgery,Western University, 4Lawson Health Research Institute

Explore More Videos

In Vivo Cytotoxicity AssayTumor-specific CD8+ T Cell ResponsesImmunodominanceTumor AntigensCytotoxic T Cell ResponsesNK CellsInnate-like T LymphocytesAdherent Tumor Cell LineTarget Splenocyte PreparationC57BL/6 Mice

Read Article

Cite this Article

Choi, J., Meilleur, C. E., Haeryfar, S. M. Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses. J. Vis. Exp. (147), e59531, doi:10.3791/59531 (2019).

Download .ris file

Copy

Share Video

.

Copy